DarkPulse Files S-1/A Amendment with Updated Financials

Ticker: DPLS · Form: S-1/A · Filed: Dec 17, 2024 · CIK: 866439

Darkpulse, INC. S-1/A Filing Summary
FieldDetail
CompanyDarkpulse, INC. (DPLS)
Form TypeS-1/A
Filed DateDec 17, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.0001, $0.0009, $19.4 million, $794,500, $10,000
Sentimentneutral

Sentiment: neutral

Topics: filing-update, financials, sec-filing

Related Tickers: DPLS

TL;DR

DarkPulse dropped updated financials in their S-1/A filing. Check 9/30/24 numbers.

AI Summary

DarkPulse, Inc. filed an S-1/A amendment on December 17, 2024, to update its financial information, including figures for the period ending September 30, 2024. The filing also includes historical financial data from previous fiscal years and quarters, such as December 31, 2023, and September 30, 2023.

Why It Matters

This amendment provides investors with the latest financial performance data for DarkPulse, Inc., crucial for evaluating the company's current health and future prospects.

Risk Assessment

Risk Level: medium — S-1/A filings often indicate a company is preparing for significant corporate actions like stock offerings, which can introduce volatility.

Key Numbers

Key Players & Entities

FAQ

What specific financial statements were updated in this S-1/A filing?

The filing indicates updates to financial information, including data for the period ending September 30, 2024, and references to previous periods like December 31, 2023, and September 30, 2023.

What is the accession number for this DarkPulse, Inc. filing?

The accession number for this filing is 0001683168-24-008790.

When was this S-1/A amendment filed?

This amendment was filed on December 17, 2024.

What is DarkPulse, Inc.'s primary business classification?

DarkPulse, Inc. is classified under SERVICES-PREPACKAGED SOFTWARE [7372].

Has DarkPulse, Inc. operated under any former names?

Yes, DarkPulse, Inc. was formerly known as KLEVER MARKETING INC (name change on 19970605) and VIDEOCART INC (name change on 19930328).

Filing Stats: 4,599 words · 18 min read · ~15 pages · Grade level 14.2 · Accepted 2024-12-17 16:38:42

Key Financial Figures

Filing Documents

RISK FACTORS

RISK FACTORS 6 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 30 PRIVATE PLACEMENT 31

USE OF PROCEEDS

USE OF PROCEEDS 31 SELLING SECURITY HOLDER 32 MARKET PRICE OF COMMON STOCK AND OTHER STOCKHOLDER MATTERS 33

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION 35

BUSINESS

BUSINESS 51 DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS 65

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 67

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 68 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 69

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 69 PLAN OF DISTRIBUTION 73 SHARES ELIGIBLE FOR FUTURE SALE 75 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 75 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS 75 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION OF SECURITIES ACT LIABILITIES 77 LEGAL MATTERS 78 EXPERTS 78 WHERE YOU CAN FIND MORE INFORMATION 78 INDEX TO FINANCIAL STATEMENTS F-1 i You should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with information different from that which is contained in this prospectus. This prospectus may be used only where it is legal to sell these securities. The information in this prospectus may only be accurate on the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of securities. ABOUT THIS PROSPECTUS The registration statement of which this prospectus forms a part that we have filed with the U.S. Securities and Exchange Commission (the " SEC ") and includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the heading "Where You Can Find More Information" before making your investment decision. You should rely only on the information provided in this prospectus or in any prospectus supplement or any free writing prospectuses or amendments thereto. Neither we, nor the Selling Security Holder, have authorized anyone else to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. You should assume that the information in this prospectus is accurate only as of the date hereof. Our business, financial condition, results of operations and prospects may have changed since that date. Neither we, nor the Selling Security Holder, are offering to sell or seek

Use of Proceeds

Use of Proceeds We will not receive any of the proceeds from any sale of the shares of Common Stock by the Selling Security Holder. We will receive proceeds from the purchase of the Common Stock under the EFA from the Selling Security Holder. See " Use of Proceeds. "

Risk Factors

Risk Factors The Common Stock offered hereby involves a high degree of risk and should not be purchased by investors who cannot afford the loss of their entire investment. See " Risk Factors " beginning on page 6. Trading Symbol The Company's Common Stock is quoted on the OTC Markets under the symbol "DPLS." The number of shares of Common Stock outstanding is based on an aggregate of 10,357,513,090 shares outstanding as of December 13, 2024, includes 271,971,823 shares of Common Stock previously sold as restricted securities under the EFA, and excludes 3,500,000,000 shares of Common Stock issuable upon purchase of the Shares under the EFA. Equity Financing Agreement Summary Following the execution of the Equity Financing Agreement dated April 28, 2023 (which was superseded by subsequent agreements up to the EFA), GHS purchased an aggregate of 271,971,823 shares of Common Stock as restricted securities which represented gross proceeds of $794,500. The EFA grants us the right, from time to time at our sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a " Put "), provided that at least five Trading Days (as defined in the EFA) have passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put shall be 92% of the Market Price with "Market Price" defined as the lowest VWAP of the Common Stock during the five consecutive Trading Days (as defined in the EFA) preceding the relevant Put Notice Date (as defined in the EFA) (the " Pricing Period "). In addition, we are required to issue to GHS shares in the amount of 115% of each Put. No Put will be made in an amount less than $10,000 or greater than $1,000,000. As a result, we may not have access to the full remaining $29,205,500 amount available under the EFA. For example, if we made a Put in the amount of $100,000 and the Market Price was $0.001, the purchase price would be $0.0

RISK FACTORS

RISK FACTORS Readers of this Prospectus should carefully consider the risks and uncertainties described below. Our failure to successfully address the risks and uncertainties described below would have a material adverse effect on our business, financial condition, and/or results of operations, and the trading price of our common stock may decline and investors may lose all or part of their investment. We cannot assure you that we will successfully address these risks or other unknown risks that may affect our business. As an enterprise engaged in the commercialization of new technology, our business is inherently risky. Our common shares are considered speculative during the development of our business operations. Prospective investors should consider carefully the risk factors set out below. Summary Risk Factors The following summarizes certain principal factors that make an investment in our Company speculative or risky, all of which are more fully described in the " Risk Factors " section herein. This summary should be read in conjunc

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing